SOURCE: Millennium Dental Technologies

Millennium Dental Technologies

November 25, 2013 11:00 ET

Big Breakthroughs in the Big Apple: Millennium Dental Technologies Showcases Clinically Proven Periodontitis Treatment Game-Changer at GNYDM

Speakers, Live Demos and Hands-On Workshops Focus on LANAP Protocol to Treat Periodontitis Less Invasively and More Effectively

CERRITOS, CA--(Marketwired - Nov 25, 2013) - Periodontal patient suffering may someday be a thing of the past due to a radically more effective, less invasive way to treat moderate to severe periodontitis -- the LANAP® protocol. A groundbreaking topic planned for multiple discussions at the Greater New York Dental Meeting (GNYDM) on December 2 and 3, 2013, Millennium Dental Technologies, developer of the FDA-cleared LANAP protocol and the manufacturer of the PerioLase® MVP-7 digital dental laser, will offer dental professionals rich educational resources via multiple speakers, live demonstrations and hands-on workshops. With a mission to change the standard of care in gum disease treatment, Millennium Dental Technologies is improving the odds -- and changing the industry -- one periodontal patient at a time.

Gone are the days of scalpels and sutures in gum disease treatment. The LANAP protocol is a patient-friendly, tissue-sparing, laser periodontitis surgery, resulting in scientifically proven regenerative outcomes. Patients experience significantly less post-operative pain, require fewer treatment sessions and enjoy quicker recovery times and lasting results.

"No matter what medical field you're in, the goal is always to achieve better patient outcomes -- and periodontal dentistry is no exception," explained Robert H. Gregg II, DDS, president and co-founder of Millennium Dental Technologies. "With the LANAP protocol, the level of improvement for the patient is so life-changing, all clinicians should embrace and offer the treatment option to their periodontitis patients." 

Dental professionals will have following opportunities to learn more about the LANAP protocol at GNYDM from December 2-3, 2013:

  • Catch Marc Nevins, DMD, MMSc on Monday, December 2 from 2 to 5 p.m. for an informative lecture on the LANAP protocol (Course 4440 / Tuition: $140). Register here:

  • Don't miss a live patient demonstration of the LANAP treatment on Tuesday, December 3 from 10 a.m. to 12:30 p.m. This must-see event features Charles Braga, DMD, MMSc performing the laser-based periodontal treatment. (Course 5040/Tuition: FREE). More here:

  • Also, learn about the LAPIP protocol -- or Laser-Mediated Periodontal Therapy -- via a hands-on workshop led by Charles Braga, DMD, MMSc, on Tuesday, December 3 from 2 to 5 p.m. (Course 5570/Tuition: $295). More here:

Millennium Dental Technologies also invites dental professionals to stop by Exhibit #4033 to speak one-on-one with company representatives. For more information about the Greater New York Dental Meeting, please visit

Headquartered in Cerritos, Calif., Millennium Dental Technologies, Inc. is the developer of the LANAP® protocol for the treatment of gum disease and the manufacturer of the PerioLase® MVP-7™ digital dental laser. By providing a less destructive and more tissue-sparing experience with unique bone-building clinical results, MDT's FDA-cleared LANAP protocol removes the fear from gum disease treatment, offering a vastly less painful and less invasive regenerative treatment alternative to conventional scalpel/suture flap surgery. The PerioLase® MVP-7 is a 6-watt free-running variable pulsed Nd:YAG dental laser featuring digital technology and 7 pulse durations -- the most available on the market -- giving it the power and versatility to perform a wide range of soft- and hard-tissue laser procedures and the only laser properly configured to support the LANAP protocol for all periodontal case types. Established in 1990, the company's founding clinicians, Robert H. Gregg, II, DDS, and Delwin K. McCarthy, DDS, continue to operate the company with a shared vision and purpose: To create better clinical outcomes in patients with periodontal disease -- and to remain true to the guiding principle -- "It's all about the patient." For more information, visit

Contact Information